ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,770.20
0.00%
US Tech 100
19,364.80
-1.56%
다우존스 지수
42,801.72
0.00%
Bitcoin
82,815.38
2.77%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Nautilus Biotechnology Inc (NAUT)

  7. Nautilus Biotechnology Inc (NAUT) 뉴스

NAUT

Nautilus Biotechnology (NAUT)

Nautilus Biotechnology Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:NAUT
일자시간출처헤드라인심볼기업
2025/03/0606:57Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:NAUTNautilus Biotechnology Inc
2025/03/0506:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NAUTNautilus Biotechnology Inc
2025/03/0506:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NAUTNautilus Biotechnology Inc
2025/03/0506:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NAUTNautilus Biotechnology Inc
2025/03/0506:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NAUTNautilus Biotechnology Inc
2025/03/0506:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NAUTNautilus Biotechnology Inc
2025/03/0506:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NAUTNautilus Biotechnology Inc
2025/02/2806:52Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:NAUTNautilus Biotechnology Inc
2025/02/2806:46Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NAUTNautilus Biotechnology Inc
2025/02/2722:00GlobeNewswire Inc.Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2024 Financial ResultsNASDAQ:NAUTNautilus Biotechnology Inc
2025/02/1822:00GlobeNewswire Inc.Nautilus Biotechnology to Participate in the TD Cowen 45th Annual Healthcare ConferenceNASDAQ:NAUTNautilus Biotechnology Inc
2025/02/0622:00GlobeNewswire Inc.Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025NASDAQ:NAUTNautilus Biotechnology Inc
2025/02/0107:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NAUTNautilus Biotechnology Inc
2024/10/3121:00GlobeNewswire Inc.Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research’s Distinguished Investigator AwardNASDAQ:NAUTNautilus Biotechnology Inc
2024/10/3021:00GlobeNewswire Inc.Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare ConferenceNASDAQ:NAUTNautilus Biotechnology Inc
2024/10/3005:06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NAUTNautilus Biotechnology Inc
2024/10/2921:00GlobeNewswire Inc.Nautilus Biotechnology Reports Third Quarter 2024 Financial ResultsNASDAQ:NAUTNautilus Biotechnology Inc
2024/10/0821:00GlobeNewswire Inc.Nautilus Biotechnology to Announce Third Quarter 2024 Financial Results on October 29, 2024NASDAQ:NAUTNautilus Biotechnology Inc
2024/09/1805:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NAUTNautilus Biotechnology Inc
2024/09/1805:40Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:NAUTNautilus Biotechnology Inc
2024/09/1721:00GlobeNewswire Inc.Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing OfficerNASDAQ:NAUTNautilus Biotechnology Inc
2024/08/1421:00GlobeNewswire Inc.Nautilus Biotechnology to Participate in the Morgan Stanley 22nd Annual Global Healthcare ConferenceNASDAQ:NAUTNautilus Biotechnology Inc
2024/07/3105:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NAUTNautilus Biotechnology Inc
2024/07/3021:00GlobeNewswire Inc.Nautilus Biotechnology Reports Second Quarter 2024 Financial ResultsNASDAQ:NAUTNautilus Biotechnology Inc
2024/07/0921:00GlobeNewswire Inc.Nautilus Biotechnology to Announce Second Quarter 2024 Financial Results on July 30, 2024NASDAQ:NAUTNautilus Biotechnology Inc
2024/06/1806:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NAUTNautilus Biotechnology Inc
2024/06/1405:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NAUTNautilus Biotechnology Inc
2024/05/2321:00GlobeNewswire Inc.Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:NAUTNautilus Biotechnology Inc
2024/04/3021:00GlobeNewswire Inc.Nautilus Biotechnology Reports First Quarter 2024 Financial ResultsNASDAQ:NAUTNautilus Biotechnology Inc
2024/04/1121:00GlobeNewswire Inc.Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024NASDAQ:NAUTNautilus Biotechnology Inc
 검색 관련기사 보기:NASDAQ:NAUT

최근 히스토리

COIN
DOGEUSD
Dogecoin
FX
USDGBP
US Dollar vs Sterling
NYSE
VZ
Verizon Communications
USOTC
BNPQY
BNP Paribas (QX)
NYSE
KO
Coca Cola
USOTC
DTEGY
Deutsche Telekom (QX)
SPI
SP500
S&P 500
USOTC
BASFY
BASF (QX)
NYSE
MRK
Merck
USOTC
RHHBY
Roche (QX)
CCOM
SILVER
SILVER
NYSE
MCD
McDonalds
CCOM
US500
US 500
NASDAQ
AAPL
Apple
AMEX
XLV
Health Care Select Sector
FX
USDJPY
US Dollar vs Yen
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지